Accuray (ARAY) Income from Non-Controlling Interests (2011 - 2025)

Accuray's (ARAY) quarterly Income from Non-Controlling Interests came in at $439000.0 in Q2 2025, up 709.72% year-on-year from $54216.1 in Q2 2024, and down 88.53% quarter-over-quarter from $3.8 million in Q4 2024.

Accuray (ARAY) Income from Non-Controlling Interests (2011 - 2025) Analysis & Trends

Accuray's Income from Non-Controlling Interests history runs 12 years deep, the most recent figure standing at $439000.0 for Q2 2025.

  • On a quarterly basis, Income from Non-Controlling Interests rose 709.72% year-over-year to $439000.0 in Q2 2025; TTM through Jun 2025 was $5.8 million, a 504.17% increase from a year earlier, with the FY2025 full-year figure at $439000.0, up 709.72% from the prior year.
  • Income from Non-Controlling Interests retreated to $439000.0 in Q2 2025 per ARAY's latest filing, from $3.8 million in the prior quarter.
  • Across five years, Income from Non-Controlling Interests topped out at $3.8 million in Q4 2024 and bottomed at -$1.2 million in Q3 2021.
  • The 5-year median for Income from Non-Controlling Interests is $431000.0 (2023), against an average of $505461.5.
  • Across the five-year window, Income from Non-Controlling Interests plunged 1114.29% in 2021 and soared 709.72% in 2025, its largest moves.
  • Year by year, Income from Non-Controlling Interests stood at $740000.0 in 2021, then surged by 162.97% to $1.9 million in 2022, then slumped by 47.17% to $1.0 million in 2023, then jumped by 272.47% to $3.8 million in 2024, then plunged by 88.53% to $439000.0 in 2025.
  • Per Business Quant, the three latest ARAY Income from Non-Controlling Interests figures stand at $439000.0 (Q2 2025), $3.8 million (Q4 2024), and $1.6 million (Q3 2024).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inc. Minority (Qtr)
1 Abbott Laboratories 183.73 Bn 176.43 Bn 6.27 Bn -
2 Stryker 129.05 Bn 126.17 Bn 3.81 Bn -
3 Medtronic 108.52 Bn 99.30 Bn 6.41 Bn 16.00 Mn
4 Boston Scientific 68.63 Bn 67.18 Bn 3.61 Bn -2.00 Mn
5 Edwards Lifesciences 48.43 Bn 44.76 Bn 1.29 Bn -
6 Dexcom 28.36 Bn 27.24 Bn 750.30 Mn -
7 GE HealthCare Technologies 28.14 Bn 25.85 Bn 1.98 Bn 22.00 Mn
8 Smith & Nephew 26.89 Bn 26.32 Bn - -
9 Koninklijke Philips 24.25 Bn 21.12 Bn 2.07 Bn -5.85 Mn
10 Accuray 28,565.06 -38.51 Mn 25.29 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2025 439,000.00
Dec 31, 2024 3.83 Mn
Sep 30, 2024 1.60 Mn
Jun 30, 2024 -72,000.00
Dec 31, 2023 1.03 Mn
Sep 30, 2023 -427,000.00
Jun 30, 2023 431,000.00
Dec 31, 2022 1.95 Mn
Sep 30, 2022 -1.07 Mn
Jun 30, 2022 -368,000.00
Dec 31, 2021 740,000.00
Sep 30, 2021 -1.17 Mn
Jun 30, 2021 -340,000.00
Dec 31, 2020 1.02 Mn
Sep 30, 2020 1.09 Mn
Jun 30, 2020 -28,000.00
Mar 31, 2020 -149,000.00
Mar 31, 2018 319,000.00
Dec 31, 2017 102,000.00
Sep 30, 2017 22,000.00